CYP19A1 and breast carcinoma: In order to examine the effect of PGRMC1 on aromatase (CYP19A1) activity in breast cancer, MCF-7 (hormone-responsive) cells were engineered for expression of an epitope-tagged aromatase and PGRMC1 was knocked down [161].